Charles Darwin University (CDU) is an Australian public university with a main campus in Darwin and eight satellite campuses in some metropolitan and regional areas. It was established in 2003 after the merger of Northern Territory University, the Menzies School of Health Research, and Centralian College.CDU is a member of the group of seven Innovative Research Universities in Australia, and offers academic degrees as well as vocational education.
This is the second of three reports arising from a research Inquiry examining Australia’s Indigenous housing system. The report examines how the system is structured, operates and is funded, and explores housing tenure choices for Aboriginal and Torres Strait Islander peoples. Current governance arrangements in the Indigenous housing system are complex and poorly coordinated. A comprehensive national Aboriginal and Torres Strait Islander housing strategy is required to align mechanisms and policies, promote greater accountability to First Nations people, and bolster self-determination in the sector. This research builds the evidence base to support the creation of a national strategy.
Household overcrowding is a major driver of acute rheumatic fever and rheumatic heart disease, along with other adverse social, cultural and health outcomes in remote Aboriginal communities. Overcrowding is compounded by poor thermal performance of current housing, energy insecurity and climate change. Despite strong evidence of the causes of rheumatic heart disease, upstream prevention through housing design remains underexplored. Wilya Janta, an Aboriginal-led organisation in Tennant Creek, has developed the Explain Home design: a culturally responsive, climate-adapted prototype designed to reduce overcrowding-related harms. With an unprecedented $4 billion investment in remote housing, health professionals have a critical role in advocating for evidence-informed, culturally safe housing as a form of preventive health intervention to improve equity and outcomes.
Background Adherence to radical cure for Plasmodium vivax remains a major challenge for malaria control programmes. Novel regimens, such as 7-day high-dose primaquine regimen and single-dose tafenoquine, may improve treatment adherence and antirelapse effectiveness but can increase the risk of haemolysis in individuals with glucose-6-phosphate dehydrogenase deficiency. Stakeholder (ie, policymakers, providers, patients, etc) perceptions of these risks may significantly influence the acceptability and uptake of these regimens. Understanding these perceptions is essential for policymakers to design effective communication and implementation strategies of novel radical cure strategies.Methods Guided by qualitative methodology and a risk perception lens, this study explored P. vivax malaria stakeholders’ experiences and interpretations of novel radical cure regimens. Between February and September 2023, 58 semistructured interviews and 6 focus group discussions were conducted at Arba Minch General Hospital and three health centres and health posts within the Gamo Zone of the South Ethiopia Regional State: Lante, Shecha and Shele. Participants included clinical trial staff and participants, health centre personnel, health extension workers and routine care patients.Results The 7-day-high-dose primaquine regimen and single-dose tafenoquine were viewed as promising solutions to the adherence challenges of the standard 14-day primaquine regimen; however, participants raised concerns about the effectiveness of the shortened treatment duration and the safety of the increased daily dose of primaquine. A risk perception lens revealed that concerns about effectiveness and safety were influenced by prior public health messaging emphasising completion of the full 14-day regimen alongside fears of overdosing and drug-induced haemolysis. Pill characteristics, including number, shape and colour as well as fears of overdosing and drug-induced haemolysis also contributed to apprehension about the safety of these regimens.Conclusion Participants’ perceptions of shortened radical cure regimens were shaped by concerns about effectiveness and safety, influenced by prior treatment messaging and pill characteristics such as higher dosing and pill burden. A risk perception lens can inform implementation and communication strategies for novel regimens, where addressing user perceptions alongside practical improvements, such as reducing pill burden, is essential for optimising uptake and adherence.
OBJECTIVE:Risk prediction models for community-acquired pneumonia (CAP) in hospitalised children are limited, especially in upper-middle-income countries. We developed a PaEdiatric Pneumonia Severity (PEPS) score to aid early risk stratification and examined its discriminatory ability. DESIGN:Prospective cohort study. SETTINGS AND PATIENTS:Between April 2022 and April 2023, children aged 1 month to <12 years hospitalised with radiographic-confirmed CAP were enrolled in Sabah, Malaysia. MAIN OUTCOME MEASURES:Key clinical factors were collected to develop risk profiles for mild, moderate, and severe CAP. The PEPS score was derived from the final multivariable model and its ability to discriminate CAP severity assessed. RESULTS:Among 868 children, 639 (73.6%) had mild, 83 (9.6%) moderate, and 146 (16.8%) severe CAP. Independent factors associated with moderate/severe CAP were age <6 months (adjusted OR (ORadj)=6.81, 95% CI 4.65 to 9.98), partial/unvaccinated status (ORadj=2.66, 95% CI 1.47 to 4.81), vomiting/refusal of feeds (ORadj=1.77, 95% CI 1.19 to 2.61), hypoxaemia (oxygen saturation 90-93% (ORadj=2.38, 95% CI 1.22 to 4.64); <90% (ORadj=28.88, 95% CI 13.37 to 62.35)) and anaemia (ORadj=1.76, 95% CI 1.17 to 2.67). The model demonstrated excellent discrimination in identifying risk of children having moderate/severe CAP (c-statistic=0.81, 95% CI 0.78 to 0.84). The developed PEPS score (0-13) stratified children into low-risk (score 0-1), moderate-risk (score 2-4) and high-risk (score ≥5) groups with observed rates of moderate/severe CAP 10.9%, 29.1%, and 76.9%, respectively, and demonstrated strong predictive performance for moderate/severe CAP (c-statistic=0.81, 95% CI 0.77 to 0.84). CONCLUSION:The PEPS score, the first developed in an upper-middle-income country using radiographic-confirmed CAP, accurately discriminates mild from moderate/severe hospitalised CAP. It may support case management in similar settings, but requires external validation before broader implementation.
Introduction Psychotic disorders often emerge from subclinical traits linked to schizotypy or bipolarity, and the crucial selective or indicated prevention could be implemented based on the identification of these. Objectives This study identifies low-risk individuals in a non-clinical population using psychometric measures, and our goal was to explore allostatic load (AL) as a marker of latent vulnerability. Methods Three groups were created based on psychometric measures, which identified 30 individuals with positive schizotypy traits (PSF), 25 with cyclothymic bipolarity traits (CF), and 30 healthy controls (HCs). Allostatic load was calculated using 21 biomarkers, and Machine learning (ML) models identified key predictive features and reduced-feature models validated robustness. Results Significant differences were observed between the three groups in the oxidative system ( p = 0.014). SHAP analysis revealed creatinine, diastolic blood pressure, uric acid, and low-density lipids as key predictors for the CF group and heart rate, TSH, uric acid, and glucose for the PSF group. Machine learning achieved 76% accuracy using all 21 biomarkers and maintained the performance using a reduced 10-biomarker model. The AL was significantly ( p = 0.010 and 0.005) lower in the CF individuals than HCs using 10 and 6 biomarkers, respectively, while no difference was shown between the PSF and HCs. Conclusions This study highlights the use of AL index in detecting early psychiatric risk. Distinct physiological patterns were observed in the PSF and CF groups. A targeted 10-biomarker AL index maintained predictive accuracy. Disclosure of Interest None Declared